Cargando…
Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625011/ https://www.ncbi.nlm.nih.gov/pubmed/23589800 http://dx.doi.org/10.5045/br.2013.48.1.67 |
| _version_ | 1782266065437327360 |
|---|---|
| author | Raut, Lalit |
| author_facet | Raut, Lalit |
| author_sort | Raut, Lalit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3625011 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-36250112013-04-15 Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis Raut, Lalit Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2013-03 2013-03-25 /pmc/articles/PMC3625011/ /pubmed/23589800 http://dx.doi.org/10.5045/br.2013.48.1.67 Text en © 2013 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Raut, Lalit Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis |
| title | Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis |
| title_full | Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis |
| title_fullStr | Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis |
| title_full_unstemmed | Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis |
| title_short | Many questions raised by a question on JAK1/2 inhibitors in primary myelofibrosis |
| title_sort | many questions raised by a question on jak1/2 inhibitors in primary myelofibrosis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625011/ https://www.ncbi.nlm.nih.gov/pubmed/23589800 http://dx.doi.org/10.5045/br.2013.48.1.67 |
| work_keys_str_mv | AT rautlalit manyquestionsraisedbyaquestiononjak12inhibitorsinprimarymyelofibrosis |